Furthermore, we measured the ATG5 levels in the above-mentioned 60 breast cancer tissues and found that the ATG5 level was upregulated in trastuzumab-resistant patient than in the trastuzumab-responding patients (Fig. 5f). The gene discussed is ATG5; the disease is breast carcinoma.